📰 Priority Review News
Page 100 - Priority Review News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priority Review. Real-time updates on events, politics, business and more.
July 22, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
July 20, 2022
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
July 19, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
July 19, 2022
SUZHOU, China, ROCKVILLE, Md. and SAN FRANCISCO, July 20, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic,...
July 19, 2022
The FDA has accepted for Priority Review the NDA for intravitreal pegcetacoplan for the treatment of geographic atrophy.
July 19, 2022
The FDA has accepted for Priority Review the BLA for lecanemab for the treatment of early Alzheimer disease.
July 13, 2022
/PRNewswire/ -- On July 11, 2022, VenusP-ValveTM, Venus Medtechs in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was...
July 13, 2022
HANGZHOU, China, July 13, 2022 /PRNewswire/ -- On July 11, 2022, VenusP-ValveTM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved by China's National Medical Products Administration (NMPA) for the treatment of severe pulmonary regurgitation (3+) in patients after congenital heart defects (CHD) procedure with native right ventricular outflow tract (RVOT). The approval has made VenusP-ValveTM the first TPVR product to be mar...
July 13, 2022
HANGZHOU, China, July 13, 2022 /PRNewswire/ -- On July 11, 2022, VenusP-ValveTM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved
July 8, 2022
Weekly dose podcast; Pharmacists now allowed to prescribe Paxlovid; new dosing recommendations for Evusheld